Filing Details
- Accession Number:
- 0001209191-11-034020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-10 14:32:53
- Reporting Period:
- 2011-06-08
- Filing Date:
- 2011-06-10
- Accepted Time:
- 2011-06-10 13:32:53
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087432 | Intermune Inc | ITMN | Pharmaceutical Preparations (2834) | 943296648 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1303832 | Allan Howard Simon | 3280 Bayshore Boulevard Brisbane CA 94005 | Svp-Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-06-08 | 8,052 | $25.55 | 48,414 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2011-06-08 | 13,124 | $15.34 | 61,538 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-06-08 | 21,176 | $32.64 | 40,362 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-06-08 | 9,578 | $33.00 | 30,784 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-06-08 | 8,052 | $0.00 | 8,052 | $25.55 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-06-08 | 13,124 | $0.00 | 13,124 | $15.34 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2014-05-15 | No | 4 | M | Direct | |
4,376 | 2015-05-13 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $32.54 to $32.915 per share. Full information on the numbers of shares sold at each sale price is available upon request.
- 25% of the shares subject to the option vest and become exercisable on May 13, 2009, and 1/36th of the shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on May 13, 2012.